A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's Disease

Authors:
  • LFLeif Freund
    Leif Freund
  • SRSten Nørby Rasmussen
    Sten Nørby Rasmussen
  • KLKarsten Lauritsen
    Karsten Lauritsen
  • NWNoel Williams
    Noel Williams
  • AMAllan S. MacDonald
    Allan S. MacDonald
  • RTRonald Tanton
    Ronald Tanton
  • FMFernando Molina
    Fernando Molina
  • MCMaria C. Campanini
    Maria C. Campanini
  • PBPaolo Bianchi
    Paolo Bianchi
  • TRTullio Ranzi
    Tullio Ranzi

Abstract
We randomly assigned 71 patients with active chronic Crohn's disease who were resistant to or intolerant of corticosteroids to treatment with oral cyclosporine (5 to 7.5 mg per kilogram of body weight per day) or placebo for three months. Disease activity was assessed on a clinical grading scale without knowledge of the treatment given.

This publication has 14 references indexed in Scilit: